We are hugely proud and delighted that Tom Powles has been named in #TIME100HEALTH of the 100 most influential people in global health this year for his transformative research on bladder cancer. TIME, Barts Cancer Institute (Queen Mary) , Barts Health qmul.ac.uk/media/news/202…

Teaching is the best part of my life, and nothing brings me more joy than sharing knowledge with my students. I strive to inspire them every day and hope that my teaching leaves a lasting impact on their lives. Barts Cancer Institute (Queen Mary)

Our first speaker Fadimana Kaya Fadimana Kaya Barts Cancer Institute (Queen Mary) presenting her PhD work #YoungEHA #BSH2024

📢 Register now for the EMBO Spatial Biology of Cancer Workshop, organised by Prof Francesca Ciccarelli (@fcicca)

🔗 meetings.embo.org/event/24-cance…

Join us from 1-3 September at The Crick for 3 days of talks, a #hackathon , posters, networking and much more.

Aaran Dokal transitioned from a postdoc at Barts Cancer Institute (Queen Mary) to the biotech world, becoming Chief Technology Officer at Kinomica, a proteomic-data science and diagnostics company.

Hear him talk about how he broke into biotech at #PostdocFutures24

Register now: bit.ly/421tfqU

Honoured to be invited to Prof Lemoine’s retirement as head of Barts Cancer Institute (Queen Mary) in the amazing Tudor great chamber at The Charterhouse where Queen Elizabeth 1st had her accession council! And be regaled by the typically dodgy ( but entertaining!) jokes of Nicholas Wright

Finally, we closed with Prof Nick Lemoine's Farewell Address, in which he reflected on the successes and challenges of the BCI over the past 20 years. Attendees gave Nick a standing ovation and raised a toast thanking him for his service as Director 👏👏👏 #BCIShowcase24

Tuesday afternoon focused on Cancer Genomics & Computational Biology, and Cancer Cell & Molecular Biology. We heard how we're using insights into cancer evolution to stay one step ahead of the disease, and how RNA 'dark matter' is shedding light on new weaknesses. #BCIshowcase24

Our Centre for Experimental Cancer Medicine presented some of the extraordinary results emerging from our clinical trials – including in triple-negative breast cancer, mesothelioma, pancreatic cancer, bowel cancer and kidney cancer – and what the future holds. #BCIShowcase24

Our second day opened with a special introductory session from our new director, Prof Nitzan Rosenfeld, who spoke about his research career to date. #BCIShowcase24

The day concluded with a fantastic keynote lecture from eriksahailab The Crick, who unpicked how the tumour microenvironment sculpts cancer invasion and therapy resistance. Thank you for joining us Erik! #BCIShowcase24

Our focus next shifted to Cancer Biomarkers & Biotherapeutics, and the Tumour Microenvironment. One highlight was hearing how we're studying London's incredibly diverse patient population to better treat people with cancer who are currently underserved. #BCIshowcase24

The showcase kicked off with sessions from our Centres for Haemato-Oncology and Tumour Biology. One common theme that emerged in both sessions was how we're working to better understand and target cancer metabolism to improve treatment. #BCIshowcase24